Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.50 Contact Hours.

Acknowledgment of Commercial Support

This educational activity is supported by an educational grant from GlaxoSmithKline.

Asthma, COPD, and the Overlap Between the Two—Comprehensive Treatment Approaches to Improve Patient Care

Release Date: August 12, 2020
Expiration Date: August 12, 2021

Activity Overview

Asthma and chronic obstructive pulmonary disease (COPD) are common airway diseases with substantial burden and negative impact on patients’ quality of life. A subset of patients have features of both asthma and COPD, described as asthma-COPD overlap (ACO), and these individuals experience significantly worse respiratory symptoms, poorer quality of life, and increased risk of exacerbations and hospital admissions.

This Community Practice Connections™ program provides an in-depth review of guideline-recommended approaches to the diagnosis and treatment of ACO. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with asthma, COPD, or ACO.
 

Acknowledgement of Support

This educational activity is supported by an educational grant from GlaxoSmithKline plc.
 

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational program is directed toward pulmonologists and allergists. Other health care professionals who treat patients with pulmonary conditions may also participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Understand the pathophysiology of asthma and COPD in the context of the development of ACO
  • Discuss the diagnostic criteria that provide an accurate diagnosis of ACO in light of asthma and COPD
  • Evaluate evidence-based therapy for the management of ACO in contrast to the management of asthma and COPD
  • Assess the role of shared decision making in developing the needed skills for proper use of delivery devices and adherence to therapy

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME guidelines, PER® has identified and resolved all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
 

Faculty

Barbara Yawn, MD
Barbara Yawn, MD
Adjunct Professor, Department of Family and Community Health
University of Minnesota
Minneapolis, MN
Chief Scientific Officer
COPD Foundation
Washington, DC

Disclosures: Grant Research Support: GlaxoSmithKline plc; Consultant: AstraZeneca plc, Boehringer Ingelheim, GlaxoSmithKline plc, Novartis AG, Sunovion Pharmaceuticals Inc

Jonathan Corren, MD
Jonathan Corren, MD
Associate Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA

Disclosures: Grant Research Support: AstraZeneca plc, Genentech Inc, Novartis AG, Regeneron Pharmaceuticals Inc, Sanofi SA; Consultant: AstraZeneca plc, Genentech Inc, Novartis AG, Regeneron Pharmaceuticals Inc, Sanofi SA; Speakers Bureau: AstraZeneca plc, Genentech Inc, Novartis AG, Regeneron Pharmaceuticals Inc, Sanofi SA

Fernando J. Martinez, MD, MS
Fernando J. Martinez, MD, MS
Chief, Division of Pulmonary and Critical Care Medicine
Bruce Webster Professor of Internal Medicine
Joan and Sanford I. Weill Department of Medicine
Weill Cornell Medical College
New York-Presbyterian Hospital/Weill Cornell Medical Center
New York, NY

Disclosures: Grant Research Support: AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim; Consultant: AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim, ProterixBio Inc, Genentech Inc, Novartis AG, Pearl Therapeutics, Theravance Biopharma Inc; Speakers Bureau: Boehringer Ingelheim, Miller Pharmaceutical Group Inc, NACE, UpToDate Inc, Novartis AG

Sally K. Miller, PhD, APRN
Sally K. Miller, PhD, APRN
Clinical Professor
Drexel University College of Nursing and Health Professions
Philadelphia, PA

Disclosures: Sally K. Miller, PHD, APRN has no relevant financial relationships with commercial interest to disclose.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
 


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
  12345
6789101112
13141516171819
20212223242526
27282930
Filter By